Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
Neuroscience Letters|April 22, 1988
The sensitivity of nigrostriatal dopamine neurons to MPP+ does not increase with ageI Irwin, G A Ricaurte, L E DeLanney, et al.Neuroscience Letters|November 6, 1989
The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in ratsK T Finnegan, J J Skratt, I Irwin, et al.Advances in Neurology|January 1, 1993
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerationsL S Forno, L E DeLanney, I Irwin, et al.Molecular Neurobiology|August 1, 1994
Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkeyL S Forno, L E DeLanney, I Irwin, et al.Brain Research|May 10, 1988
An electron microscopic study of MPTP-induced inclusion bodies in an old monkeyL S Forno, J W Langston, L E DeLanney, et al.Neurotoxicology|October 1, 1996
Astrocytes as the site for bioactivation of neurotoxinsD A Di Monte, J E Royland, I Irwin, et al.European Journal of Pharmacology|September 11, 1987
The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicityI Irwin, E Y Wu, L E DeLanney, et al.Journal of Neurochemistry|July 1, 1991
Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brainP Chan, L E DeLanney, I Irwin, et al.Experimental Neurology|April 8, 1999
Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTPT L Walters, I Irwin, K Delfani, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineK T Finnegan, I Irwin, L E Delanney, et al.Pageof 8